Structural elements and allosteric mechanisms governing regulation and catalysis of CSK-family kinases and their inhibition of Src-family kinases.

Growth Factors

Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, 3010, Australia.

Published: October 2010

C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK) are endogenous inhibitors constraining the activity of the oncogenic Src-family kinases (SFKs) in cells. Both kinases suppress SFKs by selectively phosphorylating their consensus C-terminal regulatory tyrosine. In addition to phosphorylation, CHK can suppress SFKs by a unique non-catalytic inhibitory mechanism that involves tight binding of CHK to SFKs to form stable complexes. In this review, we discuss how allosteric regulators, phosphorylation, and inter-domain interactions interplay to govern the activity of CSK and CHK and their ability to inhibit SFKs. In particular, based upon the published results of structural and biochemical analysis of CSK and CHK, we attempt to chart the allosteric networks in CSK and CHK that govern their catalysis and ability to inhibit SFKs. We also discuss how the published three-dimensional structure of CSK complexed with an SFK member sheds light on the structural basis of substrate recognition by protein kinases.

Download full-text PDF

Source
http://dx.doi.org/10.3109/08977194.2010.484424DOI Listing

Publication Analysis

Top Keywords

csk chk
12
src-family kinases
8
suppress sfks
8
ability inhibit
8
inhibit sfks
8
chk
6
sfks
6
kinases
5
csk
5
structural elements
4

Similar Publications

Article Synopsis
  • Doxorubicin, a key anticancer drug for osteosarcoma, faces challenges due to chemoresistance and its ability to increase cell migration at low doses, with MMP-2 playing a pivotal role in these processes.
  • Previous research shows MMP-2 regulates gene expression by affecting ribosomal RNA transcription and is influenced by Src kinase, which is inhibited by CHK/MATK.
  • The study suggests targeting MMP-2 may improve doxorubicin efficacy and reduce resistance by inhibiting its suppression of the tumor suppressor CHK/MATK, thereby curbing cell migration and metastasis.
View Article and Find Full Text PDF

Regulation, targets and functions of CSK.

Front Cell Dev Biol

June 2023

Department of Bio-Medical Sciences, Philadelphia College of Osteopathic Medicine, Philadelphia, PA, United States.

The Src family kinases (SFK) plays an important role in multiple signal transduction pathways. Aberrant activation of SFKs leads to diseases such as cancer, blood disorders, and bone pathologies. By phosphorylating and inactivating SFKs, the C-terminal Src kinase (CSK) serves as the key negative regulator of SFKs.

View Article and Find Full Text PDF

Protein tyrosine kinases (PTKs) are a large enzyme family that regulates many cellular processes. The key to their broad role in signaling is their tunable substrate specificity and regulatory mechanisms that allow each to respond to appropriate regulatory signals and phosphorylate the correct physiological protein substrates. Thus, in addition to the general PTK catalytic platform, each PTK acquires unique structural motifs that confer a unique combination of catalytic and regulatory properties.

View Article and Find Full Text PDF

Multiple-input-multiple-output (MIMO) communication is a technology to create high capacity wireless links. The main aim of this paper is to provide a foundation to mathematically model wireless chip to chip communication within complex enclosures. This paper mainly concentrates on modelling wave propagation between transmit and receive antennas through a phase space approach which exploits the relationship between the field-field correlation function (CF) and the Wigner distribution function (WDF).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!